3 stories about Sol-Gel
זיפים גילוח זקן

Perrigo to Collaborate with Acne Cream Company Sol-Gel on Generic Drug

Nasdaq-listed Sol-Gel is a clinical-stage company developing topical products for skin conditions
default image

Acne Cream Developer Sol-Gel files for $86 Million Nasdaq IPO

31.08.17|Dror Reich
The clinical-stage drug developer will remain a "controlled company" under current shareholder Arkin Dermatology
default image

Anti-Acne Drug Developer Plans Nasdaq IPO

15.08.17|Golan Hazani
Sol-Gel approached potential underwriters. It aims to go public before the end of the year